XML 35 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Note 13 - Income Taxes
12 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
13.
INCOME TAXES
 
 
A reconciliation of the provision of income taxes to the statutory federal income tax rate is as follows:
 
   
Year
   
Year
 
   
December 31, 2020
   
December 31, 2019
 
                 
Income Before Provision for Income Taxes
  $
7,475,241
    $
9,419,490
 
Statutory rate
   
21
%
   
21
%
Tax at statutory rate
   
1,569,801
     
1,978,092
 
State taxes, net of federal benefit
   
336,654
     
551,179
 
Permanent differences
   
18,715
     
23,889
 
Return to Provision Adjustments
   
(289,316
)
   
(113,533
)
Provision for income taxes
  $
1,635,854
    $
2,439,627
 
 
Deferred tax assets (liabilities) consist of the following: 
 
   
December 31,
2020
   
December 31,
2019
 
                 
Inventories
  $
179,171
    $
164,768
 
Bad debts
   
5,009
     
4,659
 
Accrued liabilities
   
48,812
     
279,508
 
Prepaid expense
   
(92,571
)
   
(116,524
)
Depreciation and amortization
   
(2,757,740
)
   
(2,798,040
)
Research and development and other credit carryforwards
   
451,247
     
556,387
 
Right of use lease accounting
   
47,351
     
(19,600
)
Directors stock option plan
   
161,212
     
163,427
 
Total deferred tax liability
   
(1,957,509
)
   
(1,765,415
)
Valuation allowance
   
(47,319
)
   
(47,319
)
Reserve for uncertain tax positions
   
(425,000
)    
(395,000
)
Total reserves & allowances
   
(472,319
)
   
(442,319
)
Net deferred tax liability, net of reserves
  $
(2,429,828
)
  $
(2,207,734
)
 
Valuation Allowance

The Company has a valuation allowance for deferred tax assets based upon certain credits that
may
not
be fully utilized in the future. The Company believes the valuation allowance of
$47
thousand at
December 31, 2020
and
2019,
respectively, is adequate.
 
Reserve for Uncertain Tax Positions

The Company has a reserve of unrecognized tax benefits related to exposures in accordance with ASC
740.
The Company believes the valuation allowance of
$0.4
million at
December 31, 2020
and
2019,
respectively, is adequate. Due to the uncertainties involved with this significant estimate, it is reasonably possible that the Company's estimate
may
change in the near term.
 
 
Tax Credits and Net Operating losses:
At
December 31, 2020,
the Company has state net operating losses (NOLs) and research and development (R&D) and other credit carryforwards for tax purposes which expire as follows: 
 
Tax Year
Expires
 
State NOLs
   
R& D & Other Credits
 
2021
   
-
     
3,000
 
2022
   
-
     
3,000
 
2023
   
-
     
3,000
 
2024
   
-
     
3,000
 
2025
   
-
     
3,000
 
2026
   
-
     
3,000
 
2027
   
-
     
3,000
 
2028
   
-
     
3,000
 
2029
   
191,519
     
3,000
 
2030
   
414,231
     
3,000
 
2031
   
641,229
     
3,000
 
2032
   
-
     
3,000
 
2033
   
532,837
     
3,000
 
2034
   
285,607
     
3,000
 
2035
   
-
     
-
 
2036
   
-
     
 
 
2037 and beyond
   
-
     
-
 
    $
2,065,423
    $
42,000